Thiazolidinedione use is associated with reduced risk of dementia in patients with type 2 diabetes mellitus: A retrospective cohort study

Thiazolidinedione
DOI: 10.1111/1753-0407.13352 Publication Date: 2023-01-20T08:40:45Z
ABSTRACT
Type 2 diabetes mellitus (T2DM) and dementia cause heavy health burden in mainland China, where few studies have investigated the association between glucose-lowering agents risk. We aimed to assess use of thiazolidinediones (TZDs) incidence a Chinese population with T2DM.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (46)
CITATIONS (13)